Loading…

Risks in the Drug Procurement System: Current Issues

The public procurement segment is one of the components of the pharmaceutical market in Russia. Procurement of medicines and medical devices is the top sector of public procurement, both in terms of their number and the amount of contracts concluded. The procedure for concluding state contracts itse...

Full description

Saved in:
Bibliographic Details
Published in:Propósitos y representaciones 2021, Vol.9 (2)
Main Authors: Ivanovna Zatsarinnaya, Elena, Alekseevna Prodanova, Natalia, Goncharov, Vitaliy V, Salmanovich Zhaubatyrov, Usman, Sergeevna Elizarova, Nadezda
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The public procurement segment is one of the components of the pharmaceutical market in Russia. Procurement of medicines and medical devices is the top sector of public procurement, both in terms of their number and the amount of contracts concluded. The procedure for concluding state contracts itself is spelled out in sufficient detail in the regulatory documents, but, despite this, risks may arise when concluding a state contract both for a potential applicant for a state order and for a state customer. The purpose of the study is to determine the possible risks when concluding a state contract of a healthcare institution for medicines and medical devices and ways to reduce them. El segmento de contratación pública es uno de los componentes del mercado farmacéutico en Rusia. La adquisición de medicamentos y dispositivos médicos es el principal sector de la contratación pública, tanto por su número como por la cantidad de contratos celebrados. El procedimiento para concluir contratos estatales en sí mismo se detalla con suficiente detalle en los documentos reglamentarios, pero, a pesar de esto, pueden surgir riesgos al concluir un contrato estatal tanto para un solicitante potencial de una orden estatal como para un cliente estatal. El propósito del estudio es determinar los posibles riesgos al concluir un contrato estatal de una institución de salud para medicamentos y dispositivos médicos y las formas de reducirlos
ISSN:2307-7999
2310-4635
2310-4635